Decline in serumandrogens and survival in metastatic castration resistant prostate cancer (mCRPC) patients treated with docetaxel and prednisone: results from CALGB 90401 (Alliance) Ryan, Charles J , Dutta, Sandipan , Kelly, William K , Russell, Carly ... - EAU - Eur Urol - 2018 Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401